Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma

NCT03390595 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Urothelial Cancer

Interventions

COMBINATION_PRODUCT: avelumab 10mg/kg with carboplatin/gemcitabine
COMBINATION_PRODUCT: carboplatin/gemcitabine alone

Sponsor

Associació per a la Recerca Oncologica, Spain

Collaborators

[object Object]
[object Object]